MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$2,237K
Free Cash flow
-$2,461K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from share issuance
Stock-based compensation expense
Trade and other payables
Others
Negative Cash Flow Breakdown
Net loss
Share repurchase
Share issuance costs
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Effect of exchange rate changes on cash
-
-388
269
-
Net loss
-3,883
-6,521
-6,407
-46,885
Depreciation and amortization
65
59
66
246
Unrealized loss on foreign currency remeasurement
25
-24
-13
-294
Stock-based compensation expense
1,469
2,279
2,626
2,609
Change in fair value of warrant liabilities
-380
-
-
21,925
Prepaid expenses and other current assets
-26
-51
-299
189
R&d tax incentive
186
558
364
-5,579
Trade and other payables
458
44
-5,396
1,385
Non-cash expense of eloc commitment
0
-
-
1,048
Change in fair value of convertible rights
0
-
-
-299
Non-cash interest expense
0
-
-
302
Loss on extinguishment
0
-
-
-1,472
Securities pledged
0
-
-
-
Net cash used in operating activities
-2,456
-4,622
-9,163
-12,513
Purchase of property, plant and equipment
5
4
2
8
Investment of joint venture
13
0
40
-
Net cash used in investing activities
-18
-4
-42
-8
Proceeds from share issuance
6,955
2,197
69,465
48,343
Share issuance costs
823
91
2,288
747
Warrant issuance costs
284
-
-
125
Share repurchase
1,138
1,179
-
-
Proceeds received from facility agreement
0
-
-
4,282
Repayment of facility agreement
0
-
-
4,459
Proceeds from issuance of convertible debt
0
-
-
2,779
Cancellation of warrants
-
-
-
24,769
Repayment of convertible debt
0
-
-
3,795
Debt issuance costs
0
-
-
113
Net cash provided by financing activities
4,710
927
67,177
21,396
Net increase in cash and cash equivalents
2,237
-3,700
57,972
8,875
Cash and cash equivalents at beginning of period
73,280
73,280
15,039
-
Cash and cash equivalents at end of period
74,450
69,193
73,280
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from share
issuance
$6,955K
Net cash provided by
financing activities
$4,710K
Canceled cashflow
$2,245K
Net increase in cash
and cash...
$2,237K
Canceled cashflow
$2,474K
Share repurchase
$1,138K
Share issuance costs
$823K
Warrant issuance costs
$284K
Stock-based compensation
expense
$1,469K
Trade and other
payables
$458K
Depreciation and
amortization
$65K
Prepaid expenses and
other current assets
-$26K
Net cash used in
operating activities
-$2,456K
Net cash used in
investing activities
-$18K
Canceled cashflow
$2,018K
Net loss
-$3,883K
Investment of joint venture
$13K
Purchase of property,
plant and equipment
$5K
Change in fair value of
warrant liabilities
-$380K
R&d tax incentive
$186K
Unrealized loss on foreign
currency remeasurement
$25K
Buy us a coffee
Incannex Healthcare Inc. (IXHL)
Incannex Healthcare Inc. (IXHL)